Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity.
about
Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate CancerThe androgen receptor and stem cell pathways in prostate and bladder cancers (review)Demonstration of a melanoma-specific CD44 alternative splicing pattern that remains qualitatively stable, but shows quantitative changes during tumour progressionIn vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression.Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cellsDual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.Expression of CD44 in pancreatic cancer and its significanceSuppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatmentDownregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinomaIncreased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot studyCD44 in hematological neoplasias.CD44 is a biomarker associated with human prostate cancer radiation sensitivity.SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning.Cell adhesion molecule CD44: its functional roles in prostate cancer.
P2860
Q26742062-199259AD-DD41-4AEE-AB64-2266DA958D15Q26853232-4C0F55EC-E719-4C60-860F-83FDD55C2D21Q27320755-38DF83C0-591A-46A6-ABB2-0EF4E7470BECQ28482047-5C73C451-4366-40BB-9D67-C3E0B514E2F6Q34507732-38D48EE8-AC27-4616-B904-8AD3AE9EA1B3Q35128711-C83EE4D1-7E7B-4128-B1E5-DD3EE1C0517CQ35842401-1FEA3BAD-D8AE-4660-826B-B8D53C24DBD5Q35919121-CB622812-8590-4B9E-938D-49ACBAAD6DFCQ35979751-C82032EA-F24E-4B78-B114-398F0D7A9B07Q37295787-7D5CB583-90C9-4D08-9C7B-99F9F611DCB5Q37616756-6626B32A-4C38-4EA9-A0F5-D15BEB5A1BF5Q37831812-678E6551-115C-4E84-BB9A-4960F3E13973Q39467150-EB54E2A0-E48B-4471-8A95-B28458682E79Q39947451-74D709FF-EF7A-4FCF-99DC-2DE5495A5B92Q42363361-A92BC75B-2866-4B83-AE1F-433E0CC81B57
P2860
Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Stable alterations of CD44 iso ...... binding and chemosensitivity.
@ast
Stable alterations of CD44 iso ...... binding and chemosensitivity.
@en
Stable alterations of CD44 iso ...... binding and chemosensitivity.
@nl
type
label
Stable alterations of CD44 iso ...... binding and chemosensitivity.
@ast
Stable alterations of CD44 iso ...... binding and chemosensitivity.
@en
Stable alterations of CD44 iso ...... binding and chemosensitivity.
@nl
prefLabel
Stable alterations of CD44 iso ...... binding and chemosensitivity.
@ast
Stable alterations of CD44 iso ...... binding and chemosensitivity.
@en
Stable alterations of CD44 iso ...... binding and chemosensitivity.
@nl
P2093
P2860
P356
P1433
P1476
Stable alterations of CD44 iso ...... binding and chemosensitivity.
@en
P2093
Gabriel K Habermehl
Kenneth A Iczkowski
Yaqiong Tang
P2860
P2888
P356
10.1186/1471-2407-10-16
P407
P577
2010-01-14T00:00:00Z
P5875
P6179
1005479321